Genesis BioCapital is a venture capital firm focused on creating and scaling biopharmaceutical companies pursuing transformative therapies that address significant unmet medical needs. It has a highly experienced multidisciplinary team of biopharma executives and fund operators. Genesis runs an innovative dual strategy incorporating company formation and growth investing.
Investors 1
| Date | Name | Website |
| 30.12.2024 | Eshelman V... | eshelmanve... |
Mentions in press and media 2
| Date | Title | Description |
| 12.06.2025 | 32 Biosciences: Pioneering the Future of Gut Health with $6M Funding | In the bustling landscape of biotechnology, 32 Biosciences stands out like a lighthouse in a storm. Based in North Chicago, this innovative company has recently secured $6 million in funding, propelling its mission to revolutionize gut micr... |
| 10.06.2025 | 32 Biosciences Surpasses Financing Target, Accelerates Toward Series A and FDA Milestones | Microbiome-focused company receives $6 million in funding to advance gut microbiome platform technologies NORTH CHICAGO, Ill.–(BUSINESS WIRE)–June 10, 2025– 32 Biosciences, a leader in the field of gut microbiome medicine, today announced i... |